Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Leukemia-Lymphoma, Adult T-Cell 1Head and Neck Neoplasms 1

Interventions

Lenalidomide 2Cyclophosphamide 2peginterferon alfa-2b 1etoposide phosphate 1dolutegravir 1belinostat 1Zidovudine 1Vincristine 1Tenofovir 1Raltegravir Potassium 1Prednisone 1Introns 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Doxorubicin 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia-Lymphoma, Adult T-Cell × Raltegravir Potassium × Clear all
NCT01000285 2017-03-28

ATLL

Washington University School of Medicine

Phase 1/2 Completed
18 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡